allcancercure.com

Isolagen(TM), Inc. (Amex: ILE) announced that the Food and Drug Administration (FDA) has provided follow-up on the Phase III program investigating the Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. The FDA reiterated that there are no safety issues that would prevent the initiation of the proposed studies. However, the FDA asked [...]

Up to 70% of Great Britain’s hairdressers suffer skin damage and over half of them will suffer from dermatitis at some point during their career. In support of National Hairdressers’ Day, the Health and Safety Executive (HSE) highlighted simple precautions that can prevent the debilitating disease. Dermatitis is a painful skin condition that occurs when [...]

Meyer Pharmaceuticals LLC announced that it has obtained a license for a new drug technology for the treatment of inflammatory conditions such as arthritis and skin disease. The drug is a patented oligonucleotide (a small segment of DNA) that specifically blocks NF-kB, a transcription factor that activates pro-inflammatory genes. The technology is licensed from AnGes [...]

Apollo Applied Science Pty Ltd, the over-the-counter (OTC) marketing division of biopharmaceutical company Apollo Life Sciences (AOP: ASX), has launched a unique range of advanced skincare products to be sold in Myer stores throughout Australia. Apollo’s Ellipse Skin Science products use the company’s patented Intradel™ nano-technology as well as micro-droplet emulsion and oil / water [...]

Construction workers who helped repair damaged structures after hurricanes Katrina and Rita were found to have four distinct skin disorders, according to an article published today in Archives of Dermatology (JAMA/Archives). The authors explain that skin diseases/disorders are commonly found among people after floods and hurricanes. However, not much research has been carried out after [...]

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), granted Abbott a positive opinion recommending approval of HUMIRA® (adalimumab) for the treatment of moderate to severe plaque psoriasis. Psoriasis will be the fifth disease indication for HUMIRA. Psoriasis is a non-contagious, chronic autoimmune disease that causes [...]

Two doctors from Hospital del Mar in Barcelona and UAB professors have observed, through a research carried out during the past 9 years, an increase in the number of children affected by tinea of the nails, as well as an underdiagnosis of this affection by paediatricians. In Europe, Tinea unguium has an incidence rate between [...]